Understand the Potential of Digital Signing Service (DSS)

separator

SITUATION: The global COVID-19 health crisis and its aftermath greatly impacted people’s living and business conduct. Office closures and remote work arrangements made the traditional need for a signature on paper highly inconvenient. Guidepoint’s client, a mutual fund company in Japan, saw market potential out of the new need for digital signatures. They sought our […]

Read More

デジタル署名サービス(DSS)の将来性を理解する

separator

状況: COVID-19による世界的な健康危機とその余波により、私たちの生活とビジネスにおける行動は大きな影響を受けています。オフィスが閉鎖されてリモートワークが始まり、書類への署名を要する伝統的なやり方は非常に不便なものとなりました。ガイドポイントのクライアントである日本の投資信託会社は、電子署名のニーズに市場の将来性を感じ、COVID-19によるこのニューノーマルが電子署名ビジネスにどのような機会をもたらすかをさらに理解するべく、当社に専門家サーチを依頼しました。   ソリューション: ガイドポイントジャパンのチームは、要望に応じて、以下のような点について即時的かつ正確な洞察を提供する能力を有する157人の専門家を特定することができました。   電子署名や電子契約を可能にする技術 新規かつニッチなこの市場における主要なプレイヤー 近年のパートナーシップおよび市場への影響 主要プレイヤーの競争優位性   一方、ガイドポイントは、最適な専門家をさらに絞り込むべく、クライアントとともにスクリーニングのための質問事項を設定しました。以下のアドバイザーとの間に3回のコンサルテーションを実施しました。   多国籍コンピュータソフトウェア会社の元エンジニア部門長 大手電子署名プロバイダの元セールスイネーブルメント担当副社長 米国大手ブロックチェーン技術プロバイダーのデジタル資産およびマーケット担当ディレクター   結果: コンサルテーションの後、クライアントは求めていた重要な洞察を得ることができ、電子署名業界のディールソーシング促進のための市場調査を進めることができました。   Guidepoint の詳細情報をご説明し、ご質問にお答えします。

Read More
Uncovering Timely Insights

Uncovering Timely Insights on the Treatment of Rare Diseases

separator

  CLIENT SITUATION Those afflicted by rare diseases are most vulnerable, as they count on newly developed treatments to extend and improve their quality of life. Access to accurate findings is crucial in this case, especially when it comes to identifying prevention, diagnosis, and therapy of rare diseases. This is why many centres of expertise […]

Read More

Deeper insights on the eIoT in South East Asia

separator

  CLIENT SITUATION A global electrical manufacturer was considering entering into a partnership with a third party in South East Asia (SEA) specializing in eIoT (energy Internet of Things). They needed to have a detailed assessment of the market opportunity, as well as target competitive positioning. As they are an industry leader in the eIoT […]

Read More

Five Best Practices For Conducting Expert Research

separator

Top companies and investment firms run on research. Many use research providers to connect them to knowledgeable experts who can shed light on the industries, companies, and trends that are critical to their business. Why? By working with these providers, companies can present deeper insights, faster. But in order to be effective, analysts, researchers, and […]

Read More

NEW Guidepoint Qsight Alpha Model: LivaNova

separator

by Robert Conklin, Vice President of Sales, Guidepoint Qsight With the addition of LivaNova (“LIVN”) to our Qsight Alpha product, we now have 17 company models available across the MedTech space. This timely data, gathered from over 2,000 healthcare facilities, offers clients new quantitative insights into LivaNova’s sales performance.   For LIVN, Qsight Alpha projections […]

Read More

Understanding Cross-Border B2B Payments Solutions

separator

  CLIENT SITUATION A major market research company was looking to better understand the cross-border B2B payments space. They needed to get perspectives from top-tier international banks on a tight timeline.   GUIDEPOINT SOLUTION In order to fulfill this request, the Guidepoint Professional Services team started looking for Advisors with experience at top-tier international banks […]

Read More

External Data Increases Information Governance Risks

separator

by Matthew Bernstein, Information Management Strategist at MC Bernstein Data Companies are more and more reliant on finding value in their data, while regulators, politicians, and the public are increasing their scrutiny of how companies use consumers’ data.   Massive amounts of available data, commoditized IT infrastructure (e.g., storage and compute), and presumed value to […]

Read More

(NEW) Guidepoint Qsight Model: Medtronic

separator

by Robert Conklin, Vice President of Sales, Guidepoint Data With the addition of Medtronic (“MDT”) to our Guidepoint Qsight data-sets, we now have 16 company models available across the MedTech space. This timely data, gathered from over 1,500 hospitals, offers clients new quantitative insights into Medtronic’s sales performance.   For MDT, Qsight projections have been […]

Read More

(NEW) Guidepoint Qsight Models: MMSI, CNMD, SIBN

separator

by Kenny Dolgin, Healthcare Analyst, Guidepoint Data Guidepoint Data is excited to announce that we have expanded Guidepoint Qsight’s data product offering to include models for three new companies: Merit Medical (“MMSI”), CONMED (“CNMD”), and SI-BONE (“SIBN”).   For Merit Medical, Guidepoint Qsight’s data and projection methodology has been more accurate than consensus each of […]

Read More